Difficulty: Medium
Average Score: 88%
Practice
A nurse is performing health education with a woman who has just learned that she is pregnant. The nurse has explained the concept of teratogenic drugs and emphasized the need to have her care provider assess any medications she should consider taking. The nurse should teach the woman that drug-induced teratogenicity is most likely to occur at what point in her pregnancy?
Correct answer
C
Rationale
During pregnancy, the period of organogenesis, which occurs during the first trimester, is the most critical time for the development of the fetus. This is when the major organs and structures are forming, making the fetus most vulnerable to the harmful effects of teratogenic drugs. Therefore, it is crucial for the woman to be aware of the potential risks of taking medications during this time.
Choice A, during the second half of the third trimester, is incorrect because by this time, most of the major organ systems have already developed. While exposure to teratogenic drugs at this point can still have adverse effects on the fetus, the risk is lower compared to the first trimester.
Choice B, in the 7 to 10 days after conception, is incorrect because at this early stage of pregnancy, the embryo has not yet implanted into the uterus and organogenesis has not begun. The risk of teratogenic effects is lower during this very early stage of development.
Choice D, during 30 to 34 weeks of gestation, is incorrect because by this time, the organs are fully developed, and the fetus is primarily gaining weight and maturing in preparation for birth. While exposure to teratogenic drugs at this stage can still have consequences, the risk is lower compared to the first trimester when the major organs are forming.
Choice A, during the second half of the third trimester, is incorrect because by this time, most of the major organ systems have already developed. While exposure to teratogenic drugs at this point can still have adverse effects on the fetus, the risk is lower compared to the first trimester.
Choice B, in the 7 to 10 days after conception, is incorrect because at this early stage of pregnancy, the embryo has not yet implanted into the uterus and organogenesis has not begun. The risk of teratogenic effects is lower during this very early stage of development.
Choice D, during 30 to 34 weeks of gestation, is incorrect because by this time, the organs are fully developed, and the fetus is primarily gaining weight and maturing in preparation for birth. While exposure to teratogenic drugs at this stage can still have consequences, the risk is lower compared to the first trimester when the major organs are forming.